What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Immune system
Carlo Agostini mostly deals with Immunology, Internal medicine, Bronchoalveolar lavage, Lung and Progenitor cell.
As part of his studies on Immunology, Carlo Agostini often connects relevant areas like Cytotoxic T cell.
His studies in Internal medicine integrate themes in fields like Diabetes mellitus, Endocrinology, Surgery and Cardiology.
His Bronchoalveolar lavage research includes elements of T cell, CD8 and Pathology.
His work is dedicated to discovering how Lung, Disease are connected with Rituximab, Multiple myeloma, Immunotherapy and Pathophysiology and other disciplines.
He interconnects CD34 and Angiogenesis in the investigation of issues within Progenitor cell.
His most cited work include:
- The Oral Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Increases Circulating Endothelial Progenitor Cells in Patients With Type 2 Diabetes: Possible role of stromal-derived factor-1α (272 citations)
- Antibodies to the IL-12 receptor beta 2 chain mark human Th1 but not Th2 cells in vitro and in vivo. (139 citations)
- Homeostatic chemokines drive migration of malignant B cells in patients with non-Hodgkin lymphomas (129 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Immunology, Internal medicine, Lung, Pathology and Cytotoxic T cell.
His research integrates issues of Sarcoidosis and Bronchoalveolar lavage in his study of Immunology.
His Internal medicine research also works with subjects such as
- Endocrinology which is related to area like Receptor,
- Progenitor cell and related CD34, Endothelial stem cell and Endothelium.
His Pathology research is multidisciplinary, incorporating elements of Idiopathic pulmonary fibrosis and Monoclonal antibody.
His Cytotoxic T cell study combines topics in areas such as Molecular biology, CD3, CD8 and Antibody.
Carlo Agostini combines subjects such as Tumor necrosis factor alpha and Inflammation with his study of Cytokine.
He most often published in these fields:
- Immunology (56.21%)
- Internal medicine (22.88%)
- Lung (16.10%)
What were the highlights of his more recent work (between 2012-2021)?
- Internal medicine (22.88%)
- Immunology (56.21%)
- Primary immunodeficiency (2.54%)
In recent papers he was focusing on the following fields of study:
Carlo Agostini spends much of his time researching Internal medicine, Immunology, Primary immunodeficiency, Common variable immunodeficiency and Gastroenterology.
His Internal medicine research incorporates elements of Progenitor cell, Endocrinology and Hypogammaglobulinemia.
The Progenitor cell study combines topics in areas such as CD34 and Endothelium.
His Immunology research is multidisciplinary, incorporating elements of Sarcoidosis and Disease.
His Sarcoidosis study incorporates themes from Interventional radiology, Lung, Monoclonal antibody and Pathogenesis.
He interconnects Cancer, Bronchiectasis, Pneumonia, Interstitial lung disease and Pediatrics in the investigation of issues within Common variable immunodeficiency.
Between 2012 and 2021, his most popular works were:
- Diabetes Impairs Stem Cell and Proangiogenic Cell Mobilization in Humans (115 citations)
- A possible role for B cells in COVID-19? Lesson from patients with agammaglobulinemia. (109 citations)
- An unbalanced monocyte polarisation in peripheral blood and bone marrow of patients with type 2 diabetes has an impact on microangiopathy. (82 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Immune system
His primary scientific interests are in Internal medicine, Immunology, In patient, Common variable immunodeficiency and Hypogammaglobulinemia.
His Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology, Endocrinology and Intensive care.
His work carried out in the field of Endocrinology brings together such families of science as Granulocyte colony-stimulating factor, Progenitor cell, CD34, Stem cell and Bone marrow.
He combines subjects such as Diabetes mellitus and Lung with his study of Immunology.
His research integrates issues of Cancer and Pneumonia in his study of Common variable immunodeficiency.
His Hypogammaglobulinemia research includes themes of Immunoglobulin G, Disease, Chronic lymphocytic leukemia and Standard treatment.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
